Efficacy of risperidone for the treatment of aggressive children in a private practice setting
The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of...
Main Author: | |
---|---|
Format: | Others |
Published: |
Scholarly Commons
2001
|
Subjects: | |
Online Access: | https://scholarlycommons.pacific.edu/uop_etds/2694 https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=3693&context=uop_etds |
Summary: | The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of 3 participants upon introduction of Risperdal, with the third responding in similar fashion upon final dose adjustment. Each participant reported no occurrences of side effects. These findings suggest that Risperdal was well tolerated, and may serve as a safe and effective treatment modality for this challenging population. |
---|